Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 156

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 156
---
have also entered into a Chief Financial Officer Services Agreement, or the CFO Services Agreement, dated December 5, 2022, with Shimony,
pursuant to which the Company retains CFO services from Shimony that are provided by Mr. Arie Gordashnikov. Mr. Gordashnikov, who has
been engaged by the Company since October 1, 2022, serves as the Chief Financial Officer of the Company and devotes all of the time and
effort required for our business and activities on a full-time basis. Pursuant to the CFO Services Agreement, Mr. Gordashnikov is expected
to continue to serve as our CFO following the completion of this offering, and the Company will pay Shimony $3,000 per month plus Value-Added
Tax for Mr. Gordashnikov’s services from such time as the Company completes an IPO. The CFO Services Agreement may be terminated
by either the Company or Shimony upon 60 days’ prior written notice. The CFO Services Agreement further provides that Mr. Gordashnikov
shall not provide CFO services to any third party and shall not engage in any other employment, consulting or other business activity
(whether full-time or part-time) that would create a conflict of interest with the Company. The CFO Services Agreement also includes
standard non-compete, non-solicitation and confidentiality provisions. In addition, Mr. Gordashnikov will enter into a standard indemnification
agreement with the Company.

For
a description of the terms of our options and option plans, see “Management—Equity Incentive Plan”below.

Directors’ Service Contracts

Other than with respect to
our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination
of his employment with our company.

<div align='center'>94</div>

Differences between the Companies Law and NYSE American Requirements

The Sarbanes-Oxley Act, as
well as related rules subsequently implemented by the SEC, require foreign private issuers, such as us, to comply with various corporate
governance practices. In addition, following the listing of the Ordinary Shares on NYSE American, we will be required to comply with
the NYSE American rules. Under those rules, we may elect to follow certain corporate governance practices permitted under the Companies
Law in lieu of compliance with corresponding corporate governance requirements otherwise imposed by the NYSE American rules for U.S.
domestic issuers.